您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Amisulpride-d5
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Amisulpride-d5
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Amisulpride-d5图片
包装:1mg
规格:98%
市场价:3333元
分子量:374.5

产品介绍
An internal standard for the quantification of amisulpride
货号:ajcx21658
CAS:1216626-17-3
分子式:C17H22D5N3O4S
分子量:374.5
溶解度:Chloroform: slightly soluble,Methanol: slightly soluble
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Amisulpride-d5is intended for use as an internal standard for the quantification of amisulpride by GC- or LC-MS. Amisulpride is a dopamine D2and D3receptor antagonist (Kis = 3 and 3.5 nM, respectively).1It is also an antagonist of the serotonin (5-HT) receptor subtypes 5-HT2B, 5-HT7, and 5-HT7A(Kis = 13, 11.5, and 135.5 nM, respectively). It is selective for these receptors over a panel of 39 additional receptors, ion channels, and transporters (Kis = >1,000 nM for all). Amisulpride increases 7-OH-DPAT-induced decreases in dopamine and acetylcholine release in electrically stimulated rat striatal slices (EC50s = 2.2 and 1.2 nM, respectively).2It increases the levels of dopamine and the dopamine metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in rat striatum and nucleus accumbens when administered intraperitoneally at a dose of 10 mg/kg. Amisulpride decreases immobility time in the forced swim test in rats, as well as reduces stress-induced decreases in sucrose consumption in a rat model of depression induced by chronic mild stress.3


1.Abbas, A.I., Hedlund, P.B., Huang, X.P., et al.Amisulpride is a potent 5-HT7 antagonist: Relevance for antidepressant actions in vivoPsychopharmacology (Berl.)205(1)119-128(2009) 2.Schoemaker, H., Claustre, Y., Fage, D., et al.Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivityJ. Pharmacol. Exp. Ther.280(1)83-97(1997) 3.Papp, M., and Wieronska, J.Antidepressant-like activity of amisulpride in two animal models of depressionJ. Psychopharmacol.14(1)46-52(2000)